Obesity Surgery Score (OSS) for Prioritization in the Bariatric Surgery Waiting List: a Need of Public Health Systems and a Literature Review
In the last decades, we have experienced an increase in the prevalence of obesity in western countries with a higher demand for bariatric surgery and consequently prolonged waiting times. Currently, in many public hospitals, the only criterion that establishes priority for bariatric surgery is waiting time regardless of obesity severity.
We propose a new, simple, and homogeneous clinical prioritization system, the Obesity Surgery Score (OSS), which takes into account simultaneously and equitably the time on surgical waiting list and the obesity severity based on three variables: body mass index, obesity-related comorbidities, and functional limitations. We have reviewed the current literature related to obesity clinical staging systems, and we have carried out an analysis of our patients in waiting list and divided their characteristics according to their degree of severity (A, B, or C) in the OSS. Patients with OSS grade C have a higher mean BMI, greater severity in comorbidities, and greater socio-labor impact. The current surgery waiting time of our series is of 26 months. Currently, 27 patients (51.9%) with OSS grade B and 15 patients (51.7%) with OSS grade C have been on our waiting list for more than 1 year.
Since the obesity severity, the waiting time and its clinical consequences are associated with an increase in morbidity and mortality, it is important to apply a structured prioritization system for bariatric surgery waiting list. This allows prioritization of patients at greater risk, improves patient prognosis, and optimizes costs and available health resources.
KeywordsMorbid obesity Body mass index Bariatric surgery Obesity staging Risk factors Cardiovascular diseases Waiting list Waiting time Costs Public hospitals Hospital purchasing
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
It does not apply.
Human and Animal Rights
This article does not contain any studies with human participants or animals performed by any of the authors.
- 3.Garber AJ, Abrahamson MJ, Barzilay JI, et al. Consensus statement by the American Association of Clinical Endocrinologist and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm—2017 executive summary. Endocr Pract. 2017;23(2):207–38. https://doi.org/10.4158/EP161682.CS.CrossRefPubMedGoogle Scholar
- 4.Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013 Jul;34(28):2159–219. https://doi.org/10.1093/eurheartj/eht151.CrossRefPubMedGoogle Scholar
- 6.Gabinete de Estudios Sociológicos Bernard Krief. Costes sociales y económicos de la obesidad y sus patologías asociadas: (hipertensión, hiperlipidemias y diabetes): los tratamientos de futuro y el costebeneficio generado por su aplicación en el horizonte del año 2005 en España: estudio prospectivo Delphi: libro blanco. Madrid: Bernard Krief; 1999.Google Scholar
- 12.Ministerio de Sanidad y Consumo. Disposiciones generales. núm. 134, de 5 de junio de 2003, páginas 21830 a 21840. BOE-A-2003-11266. https://www.boe.es/buscar/doc.php?id=BOE-A-2003-11266.
- 24.Kral JG. Side effects, complications and problems in anti-obesity surgery: introduction of the Obesity Severity Index. Prog Obes Res. 1996;7:655–61.Google Scholar
- 27.Emerging Risk Factors Collaboration, Wormser D, Kaptoge S, et al. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet. 2011;377(9771):1085–95. https://doi.org/10.1016/S0140-6736(11)60105-0.CrossRefGoogle Scholar
- 31.Valderhaug TG, Aasheim ET, Sandbu R, et al. The association between severity of King’s Obesity Staging Criteria scores and treatment choice in patients with morbid obesity: a retrospective cohort study. BMC Obes. 2016;3(1):51. https://doi.org/10.1186/s40608-016-0133-1.CrossRefPubMedPubMedCentralGoogle Scholar
- 36.Colquitt JL, Picot J, Loverman E, et al. Surgery for obesity. Cochrane Database Syst Rev. 2009;2:CD003641.Google Scholar